Withania somnifera (L.) Dunal ameliorates neurodegeneration and cognitive impairments associated with systemic inflammation

Abstract Background Systemic inflammation driven neuroinflammation is an event which correlates with pathogenesis of several neurodegenerative diseases. Therefore, targeting peripheral and central inflammation simultaneously could be a promising approach for the management of these diseases. Nowaday...

Full description

Bibliographic Details
Main Authors: Muskan Gupta, Gurcharan Kaur
Format: Article
Language:English
Published: BMC 2019-08-01
Series:BMC Complementary and Alternative Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12906-019-2635-0
_version_ 1828406355137921024
author Muskan Gupta
Gurcharan Kaur
author_facet Muskan Gupta
Gurcharan Kaur
author_sort Muskan Gupta
collection DOAJ
description Abstract Background Systemic inflammation driven neuroinflammation is an event which correlates with pathogenesis of several neurodegenerative diseases. Therefore, targeting peripheral and central inflammation simultaneously could be a promising approach for the management of these diseases. Nowadays, herbal medicines are emerging as potent therapeutics against various brain pathologies. Therefore, in this contemporary study, the neuroprotective activity of Ashwagandha (Withania somnifera) was elucidated against the inflammation associated neurodegeneration and cognitive impairments induced by systemic LPS administration using in vivo rat model system. Methods To achieve this aim, young adult wistar strain male albino rats were randomized into four groups: (i) Control, (ii) LPS alone, (iii) LPS + ASH-WEX, (iv) ASH-WEX alone. Post regimen, the animals were subjected to Rotarod, Narrow Beam Walking and Novel Object Recognition test to analyze their neuromuscular coordination, working memory and learning functions. The rats were then sacrificed to isolate the brain regions and expression of proteins associated with synaptic plasticity and cell survival was studied using Western blotting and Quantitative real time PCR. Further, neuroprotective potential of ASH-WEX and its active fraction (FIV) against inflammatory neurodegeneration was studied and validated using in vitro model system of microglial conditioned medium–treated neuronal cultures and microglial-neuronal co-cultures. Results Orally administered ASH-WEX significantly suppressed the cognitive and motor-coordination impairments in rats. On the molecular basis, ASH-WEX supplementation also regulated the expression of various proteins involved in synaptic plasticity and neuronal cell survival. Since microglial-neuronal crosstalk is crucial for maintaining CNS homeostasis, the current study was further extended to ascertain whether LPS–mediated microglial activation caused damage to neurons via direct cell to cell contact or through secretion of inflammatory mediators. ASH-WEX and FIV pretreatment was found to restore neurite outgrowth and protect neurons from apoptotic cell death caused by LPS-induced neuroinflammation in both activated microglial conditioned medium–treated neuronal cultures as well as microglial-neuronal co-cultures. Conclusion This extensive study using in vivo and in vitro model systems provides first ever pre-clinical evidence that ASH-WEX can be used as a promising natural therapeutic remedial for the prevention of neurodegeneration and cognitive impairments associated with peripheral inflammation and neuroinflammation.
first_indexed 2024-12-10T11:10:43Z
format Article
id doaj.art-5f84302193de4d49a64c233440ed827d
institution Directory Open Access Journal
issn 1472-6882
language English
last_indexed 2024-12-10T11:10:43Z
publishDate 2019-08-01
publisher BMC
record_format Article
series BMC Complementary and Alternative Medicine
spelling doaj.art-5f84302193de4d49a64c233440ed827d2022-12-22T01:51:25ZengBMCBMC Complementary and Alternative Medicine1472-68822019-08-0119111810.1186/s12906-019-2635-0Withania somnifera (L.) Dunal ameliorates neurodegeneration and cognitive impairments associated with systemic inflammationMuskan Gupta0Gurcharan Kaur1Department of Biotechnology, Medical Biotechnology Laboratory, Guru Nanak Dev UniversityDepartment of Biotechnology, Medical Biotechnology Laboratory, Guru Nanak Dev UniversityAbstract Background Systemic inflammation driven neuroinflammation is an event which correlates with pathogenesis of several neurodegenerative diseases. Therefore, targeting peripheral and central inflammation simultaneously could be a promising approach for the management of these diseases. Nowadays, herbal medicines are emerging as potent therapeutics against various brain pathologies. Therefore, in this contemporary study, the neuroprotective activity of Ashwagandha (Withania somnifera) was elucidated against the inflammation associated neurodegeneration and cognitive impairments induced by systemic LPS administration using in vivo rat model system. Methods To achieve this aim, young adult wistar strain male albino rats were randomized into four groups: (i) Control, (ii) LPS alone, (iii) LPS + ASH-WEX, (iv) ASH-WEX alone. Post regimen, the animals were subjected to Rotarod, Narrow Beam Walking and Novel Object Recognition test to analyze their neuromuscular coordination, working memory and learning functions. The rats were then sacrificed to isolate the brain regions and expression of proteins associated with synaptic plasticity and cell survival was studied using Western blotting and Quantitative real time PCR. Further, neuroprotective potential of ASH-WEX and its active fraction (FIV) against inflammatory neurodegeneration was studied and validated using in vitro model system of microglial conditioned medium–treated neuronal cultures and microglial-neuronal co-cultures. Results Orally administered ASH-WEX significantly suppressed the cognitive and motor-coordination impairments in rats. On the molecular basis, ASH-WEX supplementation also regulated the expression of various proteins involved in synaptic plasticity and neuronal cell survival. Since microglial-neuronal crosstalk is crucial for maintaining CNS homeostasis, the current study was further extended to ascertain whether LPS–mediated microglial activation caused damage to neurons via direct cell to cell contact or through secretion of inflammatory mediators. ASH-WEX and FIV pretreatment was found to restore neurite outgrowth and protect neurons from apoptotic cell death caused by LPS-induced neuroinflammation in both activated microglial conditioned medium–treated neuronal cultures as well as microglial-neuronal co-cultures. Conclusion This extensive study using in vivo and in vitro model systems provides first ever pre-clinical evidence that ASH-WEX can be used as a promising natural therapeutic remedial for the prevention of neurodegeneration and cognitive impairments associated with peripheral inflammation and neuroinflammation.http://link.springer.com/article/10.1186/s12906-019-2635-0AshwagandhaLipopolysaccharideMicrogliaNeuroinflammationNeuroprotectionSynaptic plasticity
spellingShingle Muskan Gupta
Gurcharan Kaur
Withania somnifera (L.) Dunal ameliorates neurodegeneration and cognitive impairments associated with systemic inflammation
BMC Complementary and Alternative Medicine
Ashwagandha
Lipopolysaccharide
Microglia
Neuroinflammation
Neuroprotection
Synaptic plasticity
title Withania somnifera (L.) Dunal ameliorates neurodegeneration and cognitive impairments associated with systemic inflammation
title_full Withania somnifera (L.) Dunal ameliorates neurodegeneration and cognitive impairments associated with systemic inflammation
title_fullStr Withania somnifera (L.) Dunal ameliorates neurodegeneration and cognitive impairments associated with systemic inflammation
title_full_unstemmed Withania somnifera (L.) Dunal ameliorates neurodegeneration and cognitive impairments associated with systemic inflammation
title_short Withania somnifera (L.) Dunal ameliorates neurodegeneration and cognitive impairments associated with systemic inflammation
title_sort withania somnifera l dunal ameliorates neurodegeneration and cognitive impairments associated with systemic inflammation
topic Ashwagandha
Lipopolysaccharide
Microglia
Neuroinflammation
Neuroprotection
Synaptic plasticity
url http://link.springer.com/article/10.1186/s12906-019-2635-0
work_keys_str_mv AT muskangupta withaniasomniferaldunalamelioratesneurodegenerationandcognitiveimpairmentsassociatedwithsystemicinflammation
AT gurcharankaur withaniasomniferaldunalamelioratesneurodegenerationandcognitiveimpairmentsassociatedwithsystemicinflammation